CILOSTAZOL ATTENUATES DIABETIC NEPHROPATHY IN RATS VIA ELEVATION OF PLASMA SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS - Egyptian Knowledge Bank - troweb

153569

CILOSTAZOL ATTENUATES DIABETIC NEPHROPATHY IN RATS VIA ELEVATION OF PLASMA SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS

Article

Last updated: 22 Jan 2023

Overview Similar Items

Article

The Efficacy of Canagliflozin on Type 2 Diabetic Nephropathy in Male Rats

Article

A DIHYDROCHALCONE AND SGLT2 INHIBITOR ABATE METHOTREXATE HEPATOTOXICITY IN MALE RATS; A COMPARATIVE STUDY

Article

Role of Cystathionine Gamma Lyasein Diabetic Nephropathy

Article

ERYTHROPOIETIN HAS AN ADDITIVE CYTOPROTECTIVE AND BENEFICIAL EFFECT TO SILDENAFIL IN A MODEL OF DIASTOLIC HEART FAILURE IN RATS

Article

THE PROTECTIVE ROLE OF THE DIPEPTIDYL PEPTIDASE-4 INHIBITOR, LINAGLIPTIN IN ACUTE AND CHRONIC KIDNEY INJURY CONDITIONS

Article

Role of AGE-RAGE Pathway in the Pathogenesis of Cardiovascular Disease as a Complication of Diabetes Mellitus

Article

AMELIORATIVE EFFECT OF PIOGLITAZONE AND ROUSVASTATIN ON HFD/STZ-INDUCED HEPATIC INJURY IN RATS

Article

The Ameliorative Effect of Proanthocyanidinsagainst Streptozotocin Induced Diabetic Nephropathy in Rats

Article

Hydroxytyrosol: A prospective preventive option for diabetic nephropathy in rats

Article

Exenatide prevents diabetic nephropathy in a rat model of type 2 diabetes mellitus (fat-fed and streptozotocin-treated rats)